An Open Pilot Study of Varenicline (Chantix) in Adult Smokers With Attention Deficit Hyperactivity Disorder (ADHD): Effects on ADHD and Cigarette Smoking.

Trial Profile

An Open Pilot Study of Varenicline (Chantix) in Adult Smokers With Attention Deficit Hyperactivity Disorder (ADHD): Effects on ADHD and Cigarette Smoking.

Discontinued
Phase of Trial: Phase IV

Latest Information Update: 20 Sep 2013

At a glance

  • Drugs Varenicline (Primary)
  • Indications Attention-deficit hyperactivity disorder; Smoking withdrawal
  • Focus Therapeutic Use
  • Most Recent Events

    • 20 Sep 2013 Last checked against ClinicalTrials.gov record.
    • 11 May 2010 Actual patient number (2) added as reported by ClinicalTrials.gov.
    • 11 May 2010 Planned end date changed from 1 Apr 2012 to 1 May 2010 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top